Current Value of Holding

$0

Shares

0

% of Portfolio

0.00%

Average Buy Price

$0.429

Avg closing price
Price range

8 Jim Simons Sonnet BioTherapeutics Holdings Trades

The first Sonnet BioTherapeutics Holdings trade was made in Q3 2021. Since then Jim Simons bought shares four more times and sold shares on three occasions. The investor sold all their shares in Q3 2023 and doesn't own any shares in Sonnet BioTherapeutics Holdings anymore.

Avg closing price
Price range
Sold -13.4 Thousand shares Q3 2023
Avg closing price $1.38
Price range $0.20 - $4.67
Increased shares by 1714.9% (+12.6 Thousand shares) Q2 2023
Avg closing price $0.40
Price range $0.22 - $0.93
New holding (+736 shares) Q1 2023
Avg closing price $0.92
Price range $0.33 - $1.41
Sold -255 shares Q3 2022
Avg closing price $3.32
Price range $1.32 - $4.35
Sold 95.6% shares (-5.59 Thousand shares) Q2 2022
Avg closing price $4.07
Price range $3.22 - $5.91
Increased shares by 438.5% (+4.76 Thousand shares) Q1 2022
Avg closing price $4.81
Price range $3.85 - $7.53
Increased shares by 189.6% (+711 shares) Q4 2021
Avg closing price $8.15
Price range $5.72 - $9.86
New holding (+375 shares) Q3 2021
Avg closing price $12.64
Price range $7.83 - $21.98

Embed chart

Easily embed the chart on your blog or website – it will always update automatically!